{"id":"https://openalex.org/W1645010355","doi":"https://doi.org/10.1038/bjc.2015.257","title":"Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours","display_name":"Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours","publication_year":2015,"publication_date":"2015-08-20","ids":{"openalex":"https://openalex.org/W1645010355","doi":"https://doi.org/10.1038/bjc.2015.257","mag":"1645010355","pmid":"https://pubmed.ncbi.nlm.nih.gov/26291057","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4559826"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.2015.257","doi":"https://doi.org/10.1038/bjc.2015.257","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2015.257","pdf_url":"https://www.nature.com/articles/bjc2015257.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/bjc2015257.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012783641","display_name":"Bojana Milojkovic Kerklaan","orcid":"https://orcid.org/0000-0003-0248-6668","observed_orcids":["https://orcid.org/0000-0003-0248-6668"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B Milojkovic Kerklaan","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078332643","display_name":"Martijn P. Lolkema","orcid":"https://orcid.org/0000-0003-0466-2928","observed_orcids":["https://orcid.org/0000-0003-0466-2928"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M P J Lolkema","raw_affiliation_strings":["Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084733864","display_name":"Lot A. Devriese","orcid":"https://orcid.org/0009-0009-9324-7814","observed_orcids":["https://orcid.org/0009-0009-9324-7814"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L A Devriese","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060207753","display_name":"Emile E. Voest","orcid":"https://orcid.org/0000-0001-8249-9586","observed_orcids":["https://orcid.org/0000-0001-8249-9586"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E E Voest","raw_affiliation_strings":["Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072151670","display_name":"A. Nol-Boekel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A Nol-Boekel","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027701365","display_name":"Marja Mergui\u2010Roelvink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M Mergui-Roelvink","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042739248","display_name":"Marlies H.G. Langenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M Langenberg","raw_affiliation_strings":["Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089464463","display_name":"Kristine Mykulowycz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Mykulowycz","raw_affiliation_strings":["Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040239544","display_name":"Joseph E Stoebenau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Stoebenau","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037114119","display_name":"Stephen R. Lane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Lane","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279159","display_name":"Philippe Legenne","orcid":"https://orcid.org/0009-0005-6586-1447","observed_orcids":["https://orcid.org/0009-0005-6586-1447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Legenne","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069473904","display_name":"Paul Stephen Wissel","orcid":"https://orcid.org/0000-0002-5790-8875","observed_orcids":["https://orcid.org/0000-0002-5790-8875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Wissel","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001448137","display_name":"Deborah Ann Smith","orcid":"https://orcid.org/0000-0003-1118-2041","observed_orcids":["https://orcid.org/0000-0003-1118-2041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D A Smith","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083781305","display_name":"Bruce J. Giantonio","orcid":"https://orcid.org/0000-0002-2475-1939","observed_orcids":["https://orcid.org/0000-0002-2475-1939"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B J Giantonio","raw_affiliation_strings":["Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J H M Schellens","raw_affiliation_strings":["Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","Science Faculty, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Science Faculty, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043481012","display_name":"Petronella Oda Witteveen","orcid":"https://orcid.org/0000-0002-8114-3075","observed_orcids":["https://orcid.org/0000-0002-8114-3075"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"P O Witteveen","raw_affiliation_strings":["Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5043481012"],"corresponding_institution_ids":["https://openalex.org/I3018483916"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":0.9529,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.70655982,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"113","issue":"5","first_page":"706","last_page":"715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":1.0},{"id":"https://openalex.org/keywords/oral-topotecan","display_name":"oral topotecan","score":0.9169999957084656},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7310000061988831},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8629999756813049},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.8349999785423279},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.5799999833106995},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.9758899211883545},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.9626227617263794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.82362300157547},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.75658118724823},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6000819206237793},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5678027272224426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5457682609558105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48192098736763},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47817760705947876},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4533124268054962},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.439095675945282},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3879584074020386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31215089559555054},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1038/bjc.2015.257","doi":"https://doi.org/10.1038/bjc.2015.257","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2015.257","pdf_url":"https://www.nature.com/articles/bjc2015257.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:26291057","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26291057","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:4559826","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4559826/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmh:oai:dspace.library.uu.nl:1874/327616","doi":null,"is_oa":false,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/327616","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/335842","doi":null,"is_oa":false,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/335842","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:umcu:oai:dspace.library.uu.nl:1874/335842","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/335842","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Cancer, 113(5), 706. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/327616","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/327616","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Cancer, 113(5), 706. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/335842","doi":null,"is_oa":true,"landing_page_url":"http://dspace.library.uu.nl/handle/1874/335842","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Cancer, 113(5), 706","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/bjc.2015.257","doi":"https://doi.org/10.1038/bjc.2015.257","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2015.257","pdf_url":"https://www.nature.com/articles/bjc2015257.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1645010355.pdf","grobid_xml":"https://content.openalex.org/works/W1645010355.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1524238852","https://openalex.org/W1603230122","https://openalex.org/W1793615273","https://openalex.org/W1823686527","https://openalex.org/W1831044128","https://openalex.org/W1859729923","https://openalex.org/W1878670617","https://openalex.org/W1910056530","https://openalex.org/W1913802169","https://openalex.org/W1960455028","https://openalex.org/W1982961953","https://openalex.org/W1988812731","https://openalex.org/W2007545333","https://openalex.org/W2009337734","https://openalex.org/W2011628325","https://openalex.org/W2023555639","https://openalex.org/W2030067727","https://openalex.org/W2049055032","https://openalex.org/W2049887075","https://openalex.org/W2054862228","https://openalex.org/W2060325999","https://openalex.org/W2068744776","https://openalex.org/W2079441406","https://openalex.org/W2090806526","https://openalex.org/W2095355415","https://openalex.org/W2095771928","https://openalex.org/W2108349673","https://openalex.org/W2111743784","https://openalex.org/W2120149213","https://openalex.org/W2124058261","https://openalex.org/W2142055223","https://openalex.org/W2156800473","https://openalex.org/W2156902079","https://openalex.org/W2158127925","https://openalex.org/W2158767575","https://openalex.org/W2161114986","https://openalex.org/W2162424705","https://openalex.org/W2166082449","https://openalex.org/W2169965478","https://openalex.org/W2202321589","https://openalex.org/W2260360964","https://openalex.org/W2478829584"],"related_works":["https://openalex.org/W2601786697","https://openalex.org/W4362459736","https://openalex.org/W2888535820","https://openalex.org/W2397878983","https://openalex.org/W2148829218","https://openalex.org/W2168635453","https://openalex.org/W2052949843","https://openalex.org/W1980177367","https://openalex.org/W2225051375","https://openalex.org/W1981260623"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"phase":[2],"I":[3,34],"study":[4,37],"evaluated":[5],"the":[6,54,131,160,171,182,244],"safety,":[7],"tolerability,":[8],"maximum":[9],"tolerated":[10,237],"dose":[11],"(MTD)":[12],"and":[13,56,68,146,157,164,192,238],"pharmacokinetics":[14],"of":[15,19,35,46,59,134,197,210,234],"two":[16],"dosing":[17],"schedules":[18,233],"oral":[20,60,186],"topotecan":[21,49,61,108,112,162,173,187,223],"in":[22,26,70,79,84,104],"combination":[23,85],"with":[24,28,86,111,130,177,200,215,230],"pazopanib":[25,47,124],"patients":[27,95,149,166,199,211],"advanced":[29],"solid":[30],"tumours.":[31],"METHODS:":[32],"Stage":[33],"this":[36],"was":[38,43],"to":[39,106],"determine":[40],"whether":[41],"there":[42],"an":[44],"impact":[45],"on":[48,64,76,123,159,170],"exposure.":[50],"In":[51,92,207],"stage":[52],"II,":[53],"MTD":[55],"safety":[57],"profile":[58,133],"given":[62],"weekly":[63,161,191,245],"days":[65,77],"1,":[66],"8":[67,189],"15":[69],"a":[71,80,101],"28-day":[72],"cycle;":[73],"or":[74],"daily-times-five":[75,172],"1-5":[78],"21-day":[81],"cycle,":[82],"both":[83,135],"daily":[87],"pazopanib,":[88,178],"were":[89,96,128,138,236],"explored.":[90],"RESULTS:":[91],"total,":[93],"67":[94],"enroled.":[97],"Pazopanib":[98],"co-administration":[99],"caused":[100],"substantial":[102],"increase":[103],"exposure":[105,224],"total":[107],"(1.7-fold)":[109],"compared":[110],"alone,":[113],"which":[114],"is":[115,225],"considered":[116],"clinically":[117],"relevant.":[118],"Topotecan":[119],"had":[120,203,212],"no":[121],"effect":[122],"concentrations.":[125],"Safety":[126],"findings":[127],"consistent":[129],"known":[132],"agents.":[136],"There":[137],"three":[139],"drug-related":[140],"deaths,":[141],"liver":[142],"failure,":[143],"tumour":[144],"haemorrhage":[145],"myelosuppression.":[147],"Two":[148],"experienced":[150,167],"dose-limiting":[151],"toxicities":[152],"(DLTs;":[153],"hand-foot":[154],"syndrome,":[155],"myelosuppression":[156],"diarrhoea)":[158],"schedule":[163],"four":[165],"DLTs":[168],"(myelosuppression)":[169],"schedule.":[174,246],"When":[175],"combined":[176],"800":[179],"mg":[180,190,194],"daily,":[181],"recommended":[183],"doses":[184],"for":[185,218],"are:":[188],"2.5":[193],"daily-times-five.":[195],"Seven":[196],"eight":[198],"partial":[201],"response":[202],"platinum-resistant":[204],"ovarian":[205],"cancer.":[206],"addition,":[208],"54%":[209],"stable":[213,217],"disease":[214],"22%":[216],"6":[219],"months.":[220],"CONCLUSIONS:":[221],"Total":[222],"1.7-fold":[226],"higher":[227],"when":[228],"co-administered":[229],"pazopanib.":[231],"Both":[232],"administration":[235],"would":[239],"permit":[240],"further":[241],"evaluation,":[242],"especially":[243]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}